about
Critical periods after stroke study: translating animal stroke recovery experiments into a clinical trialDiagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling studyImage-guided convection-enhanced delivery platform in the treatment of neurological diseases.Human/nonhuman primate AC-PC ratio--considerations for translational brain measurementsDetection of infusate leakage in the brain using real-time imaging of convection-enhanced delivery.Plasma phospholipids identify antecedent memory impairment in older adults.The use of convection-enhanced delivery with liposomal toxins in neurooncology.Gene therapy for the treatment of Parkinson's disease: the nature of the biologics expands the future indicationsThe critical need for defining preclinical biomarkers in Alzheimer's disease.Qualitative imaging of adeno-associated virus serotype 2-human aromatic L-amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson disease.Adrenal medullary autografts into the basal ganglia of Cebus monkeys: injury-induced regeneration.Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy.Cannula placement for effective convection-enhanced delivery in the nonhuman primate thalamus and brainstem: implications for clinical delivery of therapeutics.Biomarker validation: Methods and matrix matter.Systems healthcare: a holistic paradigm for tomorrow.Distribution of acid sphingomyelinase in rodent and non-human primate brain after intracerebroventricular infusion.Plasma microRNA markers of upper limb recovery following human strokePotential Metabolomic Linkage in Blood between Parkinson's Disease and Traumatic Brain InjuryFetal Bovine Serum-Derived Extracellular Vesicles Persist within Vesicle-Depleted Culture MediaResponse to "Technical approaches to reduce interference of Fetal calf serum derived RNA in the analysis of extracellular vesicle RNA from cultured cells"Tyrosine hydroxylase-immunoreactive somata within the primate subfornical organ: species specificityAuthor Correction: Plasma microRNA markers of upper limb recovery following human strokeAdvancing gene therapies, methods, and technologies for Parkinson's Disease and other neurological disorders
P50
Q28648246-927FEAAB-F261-4BF9-8DDF-EABCC10A0305Q30664901-2A17AE7E-9CA5-4CA3-AF09-79B70CB97893Q31141544-7F74FE8C-4197-4FA9-8674-8D746380CF12Q33780449-2B67E7C6-2DE9-416B-8738-177CAB113645Q37301009-A6B9EC3C-832F-453F-933D-549F32A4E43DQ37714213-F2EE499D-1ED7-4A9F-A4A4-7655F0B46A59Q37954331-A27FFFCC-7056-4CE9-9C24-E08C3193AF9AQ38166648-21843C35-53CC-42EE-BBAC-019FDC168FFFQ38219877-E30D3305-5CD9-4A94-94AA-8F4740E174CBQ39833915-7A984B65-834A-4936-A35B-B135316438E5Q41347673-EBB73C35-D6E3-47A9-A499-6C9C5EA4662CQ42232357-CCAA5433-C33F-41E7-9197-D8ABC9AC9DE3Q43599776-2371EE8C-FA9F-4209-BB06-D5495B4A3CB7Q44391054-868738A5-51D0-4A6F-BA0F-1D85728BC29AQ47281739-82A80068-E92C-4160-A4A4-1C08D71EE127Q49025068-64EA04C8-C9C4-40C0-BC90-FF6D94CC4B74Q58722282-1FD4F254-FF22-4E07-9796-F22BF8A3A093Q58758491-8C781287-1667-4F46-86C6-5A851BC54C1CQ59793617-56AC5A50-EA6D-4AA3-AE85-28863246103BQ64116648-6004C3CF-D3FD-4217-B29C-405A4F1FA786Q69925658-12CCB8EB-8E72-4896-83C4-8F5A0E5DFC3CQ89602460-ECCAF073-52FA-4578-919B-75F6705E6800Q96583971-B5D81D74-7C25-4B51-8E8A-223CBC2A04D1
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-8376-1934
@en
name
Massimo S Fiandaca
@ast
Massimo S Fiandaca
@en
Massimo S Fiandaca
@es
Massimo S Fiandaca
@nl
type
label
Massimo S Fiandaca
@ast
Massimo S Fiandaca
@en
Massimo S Fiandaca
@es
Massimo S Fiandaca
@nl
altLabel
Massimo S. Fiandaca
@en
prefLabel
Massimo S Fiandaca
@ast
Massimo S Fiandaca
@en
Massimo S Fiandaca
@es
Massimo S Fiandaca
@nl
P106
P1153
6701378549
P2798
P31
P496
0000-0002-8376-1934